<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230502058059N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-07-09</date_registration>
      <primary_sponsor>University of social welfare and rehabilitation sciences</primary_sponsor>
      <public_title>Evaluation of the effect of lumbopelvic fascial release alone with lumbopelvic and cervical fascial release on pain intensity, functional disability, pressure pain threshold, quality of life and sonoelastography indices of the fascia in both regions in non-specific chronic low back pain patients associated with neck pain</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of the effect of lumbopelvic fascial release alone with lumbopelvic and cervical fascial release on pain intensity, functional disability, pressure pain threshold, quality of life and sonoelastography indices of the fascia in both regions in non-specific chronic low back pain patients associated with neck pain</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-07-15</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>44</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/70255</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Eligible patients will be assigned to two groups based on the random block method (block size of 4 and allocation ratio 1:1) using the website www.randomization.com.
  To conceal the sequence of random allocation, numbered sealed envelopes containing group A or group B contents will be used, Blinding description: In the present study, the outcome evaluator and the person who analyzes the results will be blind to the study conditions. In this way, the questionnaires are taken by another person and the sonoelastography is performed by a radiologist and the results are analyzed by a statistician. In this study, the patients are blinded in terms of placement in the groups, but they are not blinded in terms of the type and place of treatment they receive, because the treatment process is explained to the patient. Also, the therapist is not blind and a trained and skilled physiotherapist (myself) performs fascia release.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: Low back pain. Condition 2: Neck pain.</hc_freetext>
      <i_freetext>Intervention 1: The first intervention group: they receive lumbo-pelvic fascial release. Intervention 2: The second intervention group: they receive lumbo-pelvic and cervical fascial release.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is Considering that in the ethical considerations section, we said that we do not publish the information, the data of the participants will not be published and there is no more information regarding the non-identification of individual data.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Soodeh Zandi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 42, The First Bell., West Dolatshad Ave., Farid Afshar., Zafar</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1916615463</zip>
        <telephone>+98 21 2200 6911</telephone>
        <email>soodeh.zandi@ymail.com</email>
        <affiliation>University of social welfare and rehabilitation sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Soodeh Zandi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 42, The First Bell., West Dolatshad Ave., Farid Afshar., Zafar</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1916615463</zip>
        <telephone>+98 21 2200 6911</telephone>
        <email>soodeh.zandi@ymail.com</email>
        <affiliation>University of social welfare and rehabilitation sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>People with the simultaneous complication of  non-specific chronic low back pain and  neck pain, where the intensity of low back pain is greater compared to the neck pain
Age between 20 and 55 years
Not having low back pain and neck pain caused by specific pathologies
Not receiving painkillers and anti-inflammatory drugs in the last 3-7 days
Not currently receiving physical therapy or other treatment</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>55 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>pregnancy
Not attending regular therapy sessions
Unwillingness to continue participating in the study
Infecting or developing cases (after the start of the study) that violates the criteria for entering the study for any reason</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M95.9-M99.</hc_code>
      <hc_code>M95.9-M99.</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>XIII Diseases of the musculoskeletal system and connective tissue</hc_keyword>
      <hc_keyword>XIII Diseases of the musculoskeletal system and connective tissue</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>The first intervention group: they receive lumbo-pelvic fascial release.</i_keyword>
      <i_keyword>The second intervention group: they receive lumbo-pelvic and cervical fascial release.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain score on Visual Analog Scale. Timepoint: Before the start of the intervention, at the end of the intervention and after the two-week follow-up. Method of measurement: Visual Analog Scale.</prim_outcome>
      <prim_outcome>Back disability score in back disability questionnaire. Timepoint: Before the start of the intervention, at the end of the intervention and after the two-week follow-up. Method of measurement: Oswestry Disability Index.</prim_outcome>
      <prim_outcome>Neck disability score in neck disability questionnaire. Timepoint: Before the start of the intervention, at the end of the intervention and after the two-week follow-up. Method of measurement: Neck Disability Index.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Pressure pain threshold score. Timepoint: Before the start of the intervention, at the end of the intervention and after the two-week follow-up. Method of measurement: Algometer tool.</sec_outcome>
      <sec_outcome>Quality of life score. Timepoint: Before the start of the intervention, at the end of the intervention and after the two-week follow-up. Method of measurement: Short form health survay.</sec_outcome>
      <sec_outcome>Fascia elasticity. Timepoint: Before the start of the intervention, at the end of the intervention and after the two-week follow-up. Method of measurement: Sonoelastography.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>University of social welfare and rehabilitation sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-03-15</approval_date>
        <contact_name>Research Ethics Committees of University of Social Welfare and Rehabilitation Sciences</contact_name>
        <contact_address>First bell, No. 42, Dolatshad West St., Farid Afshar St., Zafar St Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
